Stem cell treatment for age-related neurodegenerative diseases

The belief in the inability of neurogenesis, that is the inability to create new neurons after embryonic and early postnatal development of the central nervous system, was rejected in the mid-nineties, when the existence of neurogenesis in restricted areas of CNS adult mammals, including humans, was...

Full description

Bibliographic Details
Main Authors: Nurković J., Bisevac B., Mustafić F., Hajrovic S., Regić E., Nurković S., Kurtagić I., Dolicanin Z.
Format: Article
Language:English
Published: Medicinski fakultet Priština, Društvo lekara Kosova i Metohije Srpskog lekarskog društva 2015-01-01
Series:Praxis Medica
Subjects:
Online Access:http://scindeks-clanci.ceon.rs/data/pdf/0350-8773/2015/0350-87731502103N.pdf
Description
Summary:The belief in the inability of neurogenesis, that is the inability to create new neurons after embryonic and early postnatal development of the central nervous system, was rejected in the mid-nineties, when the existence of neurogenesis in restricted areas of CNS adult mammals, including humans, was discovered.Transplantation of stem cells or their derivatives into respective tissues or organs is considered as one of the most promising remedies for many incurable diseases.In this review, we summarized current knowledge and present and future perspectives andchallenges regarding stem cells treatment for Parkinson's and Alzheimer's disease, as the most common age-related neurodegenerative diseases.
ISSN:0350-8773